Back to Agenda
Session 4: Report Back from the Roundtable Discussions (Sessions 2 and 3) & Panel Discussion
Session Chair(s)
Niklas Hedberg, MPHARM
HTACG Co-Chair & Chief Pharmacist, Dental and Pharmaceutical Benefits Agency, TLV, Sweden
In this session, the facilitators of the various roundtable discussions will share the main conclusions and any identified next steps from their table. A Panel composed by representatives of the various stakeholders will comment the conclusions shared and provide further insights into next steps and their work plan for 2024.
Speaker(s)
Niklas Hedberg, MPHARM
HTACG Co-Chair & Chief Pharmacist, Dental and Pharmaceutical Benefits Agency, TLV, Sweden
Francesca Cerreta, PHARMD, MPHARM, MS
Principal Scientific Officer, European Medicines Agency, Netherlands
Alexander Natz, JD
Secretary General, European Confederation of Pharmaceutical Entrepreneurs, Belgium
Ansgar Hebborn, PHD, MBA
Head - Access Policy Affairs Europe, F. Hoffmann-La Roche AG, Switzerland
Have an account?